Abstract
Objective: Although non-small cell lung cancer (NSCLC) involving the superior sulcus has been generally treated with radiation therapy (RT) followed by surgery, local recurrence is still a big problem to be solved. We investigated a role of induction therapy, especially induction concurrent chemoradiation therapy (CRT), on the surgical results of this type of NSCLC. Method: We retrospectively reviewed 30 patients with NSCLC invading the apex of the chest wall who underwent surgery from 1987 to 1996. Ten patients (57±8 years) received surgery alone, 9 (55±13 years) received RT (42±7 Gy) followed by surgery and 11 (51±9 years) received cisplatin based chemotherapy and RT (47±5 Gy) as an induction therapy. Results: Two and 4-year survival rates were 30% and 20% in patients with surgery alone, 22% and 11% in patients with induction RT, and 73% and 53% in patients with induction CRT, respectively. The survival was significantly better in patients with induction CRT than those with induction RT or surgery alone. Univariate analysis demonstrated that curability (yes versus no: p=0.027) and induction therapy (surgery alone and RT versus CRT: p=0.0173) were significant prognostic factors. Multivariate analysis revealed that only induction therapy (p=0.0238) was a significant prognostic factor. Conclusions: Induction CRT seems to improve the survival in patients with NSCLC invading the apex of the chest wall compared with induction RT or surgery alone.
Similar content being viewed by others
References
Shaw RR, Paulson DL, Kee JL. Treatment of the superior sulcus tumor by irradiation followed by resection. Ann Surg 1961; 154: 29–40.
Paulson DL. Carcinomas in the superior pulmonary sulcus. J Thorac Cardiovasc Surg 1975; 70: 1095–104.
Wright CD, Moncure AC, Shepard JA, Wilkins EW Jr, Mathisen DJ, Grillo HC. Superior sulcus lung tumors: Results of combined treatment (irradiation and radical resection). J Thorac Cardiovasc Surg 1987; 94: 69–74.
Strauss GM, Herndon JE, Sherman DD, Mathisen DJ, Carey RW, Choi NC, et al. Neoadjuvant chemotherapy and radiotherapy followed by surgery in stage IIIA non-small-cell carcinoma of the lung: Report of a cancer and leukemia group B phase II study. J Clin Oncol 1992; 10: 1237–44.
Rusch VW, Albain KS, Crowley JJ, Rice TW, Lonchyna V, McKenna R Jr, et al. Surgical resection of stage IIIA and stage IIIB non-small-cell lung cancer after concurrent induction chemoradiotherapy: A Southwest Oncology Group Trial. J Thorac Cardiovasc Surg 1993; 105: 97–106.
Martinez-Monge R, Herreros J, Aristu JJ, Aramendia JM, Azinovic I. Combined treatment in superior sulcus tumors. Am J Clin Oncol 1994; 17: 317–22.
Attar S, Krasna MJ, Sonett JR, Hankins JR, Slawson RG, Suter CM, et al. Superior sulcus (Pancoast) tumors: Experience with 105 patients. Ann Thorac Surg 1998; 66: 193–8.
Rusch VW, Giroux DJ, Kraut MJ, Crowley J, Hazuka M, Johnson D, et al. Induction chemoradiation and surgical resection for non-small cell lung carcinomas of the superior sulcus: Initial results of Southwest Oncology Group Trial 9416 (Intergroup Trial 0160). J Thorac Cardiovasc Surg 2001; 121: 472–83.
Wright CD, Menard MT, Wain JC, Donahue DM, Grillo HC, Lynch TJ, et al. Induction chemoradiation compared with induction radiation for lung cancer involving the superior sulcus. Ann Thorac Surg 2002; 73: 1541–4.
Miyoshi S, Maebeya S, Suzuma T, Bessyo T, Hirai I, Tanino Y, et al. Induction therapy of invading apical lung cancer. Proceedings of XXX World Congress of The International College of Surgeons, Kyoto, November 25–29, 1996: 995–9.
Masaoka A, Ito Y, Yasumitsu T. Anterior approach for tumor of the superior sulcus. J Thorac Cardiovasc Surg 1979; 78: 413–5.
Mountain CF. Revisions in the international system for staging lung cancer. Chest 1997; 111: 1710–7.
Ginsberg RJ, Martini N, Zaman M, Armstrong JG, Bains MS, Burt ME, et al. Influence of surgical resection and brachytherapy in the management of superior sulcus tumor. Ann Thorac Surg 1994; 57: 1440–5.
Shahian DM, Neptune WB, Ellis FH Jr. Pancoast tumors: Improved survival with preoperative and postoperative radiotherapy. Ann Thorac Surg 1987; 43: 32–8.
Maggi G, Casadio C, Pischedda F, Giobbe R, Cianci R, Ruffini E, et al. Combined radiosurgical treatment of Pancoast tumor. Ann Thorac Surg 1994; 57: 198–202.
Sartori F, Rea F, Calabro F, Mazzucco C, Bortolotti L, Tomio L. Carcinoma of the superior pulmonary sulcus: Results of irradiation and radical resection. J Thorac Cardiovasc Surg 1992; 104: 679–83.
Martin J, Ginsberg RJ, Abolhoda A, Bains MS, Downey RJ, Korst RJ, et al. Morbidity and mortality after neoadjuvant therapy for lung cancer: The risk of right pneumonectomy. Ann Thorac Surg 2001; 72: 1149–54.
Fowler WC, Langer CJ, Curran WJ, Keller SM. Postoperative complications after combined neoadjuvant treatment of lung cancer. Ann Thorac Surg 1993; 55: 986–9.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Miyoshi, S., Iuchi, K., Nakamura, K. et al. Induction concurrent chemoradiation therapy for invading apical non-small cell lung cancer. Jpn J Thorac Caridovasc Surg 52, 120–126 (2004). https://doi.org/10.1007/s11748-004-0127-7
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s11748-004-0127-7